The fungicide imazalil (IMZ) is widely used to prevent and treat fungal diseases in plants and animals. Here, male adult C57BL/6 mice were exposed to 0.1, 0.5, and 2.5 mg/kg body weight IMZ for 2, 5, or 15 weeks. The microbiota in cecal contents and feces changed during chronic IMZ exposure at phylum and genus levels. Sequencing of the V3-V4 region of the bacterial 16S rRNA gene revealed a significant change in the richness of microbiota in cecal contents and feces after exposure to 2.5 mg/kg IMZ for 15 weeks. Operational taxonomic unit (OTU) analysis indicated that 31.1% of cecal OTUs and 14.0% of fecal OTUs changed after IMZ exposure. In addition, chronic IMZ exposure also disturbed the intestinal barrier function of the mice, reducing mucus secretion, decreasing the expression of cystic fibrosis transmembrane conductance regulator (CFTR)-related genes in both the ileum and colon. Molecular docking analysis revealed that key hydrogen bonds were formed by nitrogen atoms of the imidazole bond with Val440 of CFTR and Ala697 of the SLC26 family. Our data suggested that gut microbiota and intestinal barrier were potential toxicological targets of IMZ.
A large number of studies have shown that the intestinal tract plays an extremely important role in the occurrence and development of disease (Breton et al., 2013; Tomas et al., 2016) . The intestinal tract is the largest microecosystem of the human body, with up to 10 14 gut microbes across more than 1000 varieties forming a mutualistic relationship with the body (Sekirov et al., 2010) . The intestines are not only the major organs of digestion and absorption but also the body's largest immune organ and an important line of defense, accounting for more than 80% of the immune cells in the immune system, to protect against invasion by harmful substances (Magalhaes et al., 2007) . The intestinal barrier, a complex with multiple capabilities, is composed of intestinal epithelial cells (IECs) and tight junctions of intestinal mucous cells. The intestinal barrier consists of a mechanical barrier, a chemical barrier, a biological barrier and an immune barrier, and each barrier plays a substantial defense role in the mucous membrane of the enteron (Farhadi et al., 2003; Newberry and Lorenz, 2005; Garret et al., 2010) . The intestinal barrier assumes an important role in a stable microecosystem: (1) The surface of the gut lumen has a thick mucus layer in contact with a large number of microorganisms, and the secreted mucin can protect the intestinal mucosa and resist penetration by bacteria (Linden et al., 2008) ; (2) The dynamic stability of the microecosystem can maintain intestinal barrier function and prevent abnormal immune responses by the mucosa (Artis, 2008) ; (3) Tight junctions in the intestinal tract seal the gaps between adjacent IECs and keeps substances such as antigens and microbes contained in the lumen (Turner, 2009 ); (4) Immunoglobulin A, pattern recognition receptor, and antimicrobial peptide (AMP) can limit the population of gut microbes and prevent bacterial invasion (Duerkop et al., 2009) . Under normal circumstances, the intestinal microecological structure remains relatively stable; in pathological cases, pathogenic microorganisms and their metabolic products adhere to the mucous membrane, passing into the bloodstream through the intestinal barrier, and then initiate a local inflammatory response, leading to bowel disease (Round and Mazmanian, 2009 ). Thanks to the growing body of research, the role of gut microbiota has been becoming increasingly unambiguous (Janssen and Kersten, 2015; Hand et al., 2016) . Recently, quite a few researchers proposed the gut microbiota as a possible target to manage the health of the host (Gilbert et al., 2016) . At the same time, studies of animal gut microbiota should also pay attention to environmental factors that can affect intestinal flora . The possible effects of antibiotics, endocrine disruptors, and pesticide residues on animal or gut microbiota and the subsequent damage deserve more attention Jin et al., 2016c Jin et al., , 2017b .
In a previous study, we observed that oral administration of high doses (25, 50, 100 mg/kg) of IMZ to male ICR mice for 28 days resulted in gut microbiota dysbiosis and colonic inflammation (Jin et al., 2016a) . In practice, though, it is necessary and more important to evaluate the health risk of an environmentally relevant concentration in most cases. For IMZ, according to the World Health Organization (WHO), the maximum allowable residue levels are 5 mg/kg in citrus fruits and 2 mg/kg in bananas (Tanaka et al., 2013) . To better understand the toxicological mechanisms involved in low-dose IMZ exposure, we chronically exposed to C57BL/6 mice to 0.1, 0.5, and 2.5 mg/kg IMZ dissolved in pure water for 2, 5, and 15 weeks. Subsequently, the main parameters of gut microbiota composition, metabolomic responses and the transcriptional levels of genes relevant to mucus secretion and ionic transport in the intestine were analyzed. We hope that these results can bring some new insight into the potential risks of low-dose IMZ exposure to human health.
MATERIALS AND METHODS
Chemicals, animal care and experimental scheme. Imazalil was purchased from Adamas (CAS: 35554-44-0, purity: !97%). Imazalil was directly dissolved in pure water for experimental use. A total of 108 five-week-old male C57BL/6 mice were purchased from the China National Laboratory Animal Resource Center (Shanghai, China). The mice were individually housed in an animal facility at 22 C 6 1 C with a photoperiod of 12 h light and 12 h dark for 1 week prior to the start of treatment. All the mice were randomly assigned to 4 groups, the control group (CON), and 3 groups of mice were orally administered 0.1, 0.5, and 2.5 mg/kg body weight IMZ (IMZ-0.1, IMZ-0.5, IMZ-2.5) per day, respectively. The selected doses were equal or lower than the maximum allowable residue levels in plant form the WHO. The control and 2.5 mg/kg groups contained 30 mice per group, while the 0.1 and 0.5 mg/kg groups contained 24 mice per group). All mice were fed a basal diet throughout all experiments. Water and food were available ad libitum. During IMZ exposure, the feces from each mouse were collected once a week until sacrifice. Eight mice from each group were sacrificed after 2, 5, and 15 weeks of IMZ exposure, respectively. The remaining 6 mice in the control and 2.5 mg/kg IMZ-treated groups were then maintained for an additional 45 days without IMZ treatment while the feces were collected weekly to assess the recovery of gut microbiota. At the end of experiment, all remaining mice were fasted for 8 h and anesthetized with ether before being killed. The ileum and colon tissues and cecal content were collected and frozen in liquid nitrogen immediately. All experiments were performed in accordance with the Guiding Principles in the Use of Animals in Zhejiang University of Technology, and every effort was made to minimize animal suffering.
Histochemical analyses of the mice colon. The colons of 3 mice in each group were selected randomly for histopathological analysis. Briefly, the paraformaldehyde-fixed colon tissues were cut into 5-lm-thick sections embedded in paraffin, fixed in 0.1% (w/v) formaldehyde, and then stained with Alcian Blue-periodic acid-Schiff (AB-PAS) stain. The mucus secretion coverage ratio was determined using an image analyzer (Image-pro Plus 6.0).
DNA extraction, PCR amplification, quantification, and 16S rRNA gene sequencing. Microbial genomic DNA (gDNA) was extracted from freeze-dried cecal contents and fecal samples using a commercial magnetic bead DNA isolation kit provided by Hangzhou Foreal Nanotechnology following the manufacturer's instructions. Microbial gDNA extracted from the cecal contents or fecal pellets was amplified using general primer (forward primer: 5 0 -ACTCCTACGGGAGGCAGCAG-3 0 ; reverse primer: 5 0 -GGACTA CHVGGGTWTCTAAT-3 0 ) to target the V3 and V4 regions of the bacterial 16S rRNA gene. In this study, the composition of the gut microbiome from 5 mice in each group was determined by dual-indexing amplification and sequencing on the Illumina MiSeq platform followed by QIIME (version 1.9.1) bioinformatic analysis. In addition, portions of the gDNA were amplified by Real-Time qPCR with bacterial phylum-specific primers (Supplementary Table 2 ) according to a previous study . The following cycling conditions were used as: 50 C for 2 min, 95 C for 10 min, 95 C for 15 s, 56 C for 30 s, and 72 C for 1 min, repeated for 40 cycles; and 72 C for 10 min.
Total RNA extraction and gene expression analysis. Total RNA was extracted from the tissues using TRIzol reagent (Takara Biochemicals, Dalian, China), and cDNA was synthesized using a reverse transcriptase kit (Toyobo, Tokyo, Japan). RT-qPCR was performed using a reverse transcriptase kit with SYBR Green (Toyobo, Tokyo, Japan) in an Eppendorf MasterCycler ep RealPlex 2 thermocycler (Wesseling-Berzdorf, Germany). Gene-specific primer sequences for cystic fibrosis transmembrane conductance regulator (Cftr), nkcc1, SCL26A3, SCL26A6, Ano1, Nhe3, Muc1, Muc2, Muc3, Klf4, Meprin-b, Retnlb are listed in Supplementary Table 3 . The transcription level of 18S rRNA gene was also determined as a housekeeping gene. The following cycling conditions were used to amplify cDNA: Denaturation for 1 min at 95 C, followed by 40 cycles of 15 s at 95 C and 1 min at 60 C. The PCR and quantification of relative gene expression were performed as previously described (Livak and Schmittgen, 2001; Liu et al., 2017) .
Determination of the protein levels of CFTR, NKCC1, and SLC26A3 in the ileum and colon. Portions of tissue from the ileum and colon were defrosted and homogenized separately with 100 ll of icecold PBS per sample. The protein levels of CFTR, NKCC1, and SLC26A3 in the supernatant from each mouse were determined with the corresponding mouse ELISA kits (RapidBio) according to the manufacturer's instructions. The ELISA assays were measured on a microplate reader (Power wave XS, Bio-TEK, USA) using a 96-well microwell plate.
Molecular docking. Molecular docking analysis was performed to establish the binding modes of IMZ to mouse CFTR and the SLC26 family using AutoDock Vina 1.1.2. (http://vina.scripps.
edu/). The 3 crystal structures of mouse CFTR (PDB code: 3SI7) and SLC26 (PDB code: 3LLO) were downloaded from the RCSB Protein Data Bank (http://www.rcsb.org/pdb/home/home.do). AutoDock Tools (ADT) 1.5.6 (http://mgltools.scripps.edu) was applied to set the size and coordinates of the grid box and to generate the input files. The exhaustiveness was set to a value of 20. For each complex, 10 independent docking runs were conducted, out of which the binding mode with the lowest binding energy was chosen and visually analyzed using PyMOL software (http://www.pymol.org) (Trott and Olson, 2010) .
Statistical analysis. Differences between 2 or more groups were evaluated by one-way ANOVA followed by Dunnett's test or Fisher's protected least significant difference test using SPSS 13.0 (SPSS, Chicago, Illinois). Values are expressed as the mean 6 SEM. Each IMZ-treated group was compared with the corresponding control group.
RESULTS

Chronic IMZ Exposure Induced Changes in Gut Microbiota
The qPCR results showed that the relative abundance of Bacteroidetes decreased significantly in the cecal contents of both 0.5 and 2.5 mg/kg IMZ-treated groups after 2, 5, and 15 weeks (Figs. 1A-C). The relative abundance of Firmicutes was lower in the mice fed 0.5 and 2.5 mg/kg IMZ after 2 weeks ( Figure  1A ) but was nonetheless significantly higher than that in the mice exposed to 0.1 or 0. For c-Proteobacteria, the relative abundances reduced significantly in cecal contents of all IMZ-treated groups (Figs. 1A-C). In addition, it was observed that the relative abundances of Bacteroidetes, Firmicutes, b-Proteobacteria, and c-Proteobacteria in the feces altered in IMZ-treated groups compared with the control group, even after only 2 weeks of exposure. However, the abundances of Actinobacteria and a-Proteobacteria changed after 5 weeks of exposure, and the impact continued to the end of the exposure (Figs. 1D-I). Specifically, the relative abundance of Bacteroidetes had a tendency to increase while the relative abundances of Firmicutes, Actinobacteria and a-, b-, c-Proteobacteria had a tendency to decrease in the feces after IMZ exposure for 15 weeks.
To further illustrate the effects of exposure to 2.5 mg/kg IMZ for 15 weeks on the composition of the microbiota in cecal contents and feces, high-throughput sequencing of the V3-V4 region of the 16S rRNA gene was used for the deep analysis. Sequencing results indicated that the 15 weeks IMZ exposure relatively decreased the species number of bacteria in mice cecal contents but significantly increased the number in mice fecal contents, this change was confirmed by the Chao1 level changes (Table 1) . But IMZ did not change the diversity of mice gut microbiota both in the cecal and fecal contents (Table 1) . Among the 836 OTUs identified in cecal contents, there were 127 fewer OTUs and 393 OTUs with different levels of abundance than in the control group after exposure to 2.5 mg/kg IMZ for 15 weeks. In feces, 277 of the 1046 identified OTUs were changed significantly by 2.5 mg/kg IMZ exposure (Figure 2A ). In total, approximately 31.1% of cecal OTUs and 14.0% of fecal OTUs changed after IMZ exposure (Figure 2A ). According to UniFrac weighted principal co-ordinate analysis (PCoA), the gut microbiota of IMZ-treatment deviated from the control both in mice cecal contents and feces ( Figure 2B) . At the phylum level, Bacteroidetes, Firmicutes, Proteobacteria, TM7, and Acidobacteria were most abundant in the feces, making up 59.66%, 33.72%, 6.16%, 0.26%, and 0.08%, respectively, of all identified OTUs. The main OTUs identified at the genus level in the cecal contents and feces are shown in Figure 2C . The proportions of S24-7, Prevotella, Bacteroidetes, and Parabacteroides decreased in the cecal contents and the feces, whereas the proportion of Clostridiales, Oscillospira and Helicobacteraceae increased after 15 weeks of IMZ treatment ( Figure 2D ). In addition, it was observed that the abundances of Prevotella, Oscillospira, Helicobacteraceae, Bacteroides acidifaciens, Parabacteroides distasonis, and Lactobacillus reuteri at the species level were significantly different from the values in the control group, and their possible physiological roles have been listed in Supplementary Table 1.
Chronic IMZ Exposure Altered the Secretion of Mucus and Transcription of Some Related Genes in Colon As shown in colon tissue stained with AB-PAS, significant decreases in the secretion of mucin were revealed in the colon of mice that were exposed to 0.1, 0.5, and 2.5 mg/kg IMZ for 5 or 15 weeks (Figs. 3A-D) . The mRNA levels of the main genes related to secretion of mucin in colon were also altered by chronic IMZ exposure. Briefly, the relative mRNA levels of Muc2 and Meprin-b decreased significantly in colon after 2 weeks of exposure to 2.5 mg/kg IMZ ( Figure 3E ). When the exposure was extended to 5 weeks, the transcription levels of Muc1, Muc3, Klf4, Meprin-b, and Retnlb all tended to decrease, especially in the 2.5 mg/kg IMZ-treated group ( Figure 3F) . However, the mRNA levels of Muc1, Muc2, Muc3, Meprin-b, and especially Retnlb increased significantly in colon of mice that were chronically exposed to a low dose of IMZ for 15 weeks ( Figure 3G ). In addition, the ratio of bacterial 16S ribosomal gene to eukaryotic 18S ribosomal gene significantly increased in colon of mice treated with 0.5 and 2.5 mg/kg IMZ for 2, 5, and 15 weeks, indicating that more gut bacteria were disseminated in colon after chronic IMZ exposure ( Figure 3H ).
IMZ Altered Ionic Transport in the Intestine via CFTR Dysfunction
Here, we measured the relative mRNA levels of the major ionic transporters including Cftr, nkcc1, SLC26A3, SLC26A6, Ano1, and Nhe3 in ileum (small intestine) and colon (large intestine) of mice after exposure to IMZ for 2, 5, and 15 weeks. The mRNA levels of Cftr, nkcc1, SLC26A3, SLC26A6, Nhe3 in ileum, and nkcc1 in colon were significantly down-regulated in the group exposed to 2.5 mg/kg IMZ for 2 weeks (Figs. 4A and 4G ). When the exposure period was extended to 5 weeks, the mRNA levels of Cftr, nkcc1, SLC26A3, SLC26A6, Ano1, and Nhe3 decreased significantly in ileum of mice exposed to 0.5 and 2.5 mg/kg IMZ ( Figure  4B ). In addition, the mRNA levels of Cftr, nkcc1, SLC26A3, and Ano1 in colon of mice treated with 2.5 mg/kg IMZ were much lower than those in the control group ( Figure 4H) . Furthermore, the transcriptional levels of all CFTR-related genes in ileum and of Cftr, nkcc1, SLC26A3, SLC26A6, Ano1 in colon decreased significantly when the mice were exposed to 0.1, 0.5, and 2.5 mg/kg IMZ for 15 weeks (Figs. 4C and 4I) . Furthermore, in both ileum and the colon, the protein levels of CFTR, NKCC1, and SLC26A3 were significantly down-regulated in the 0.5 and 2.5 mg/kg IMZtreated groups (Figs. 4D-F and J-L). In addition, the protein levels of CFTR, NKCC1, and SLC26A3 decreased significantly in ileum, and CFTR and NKCC1 in colon, when the mice were exposed to 0.1 mg/kg IMZ for 15 weeks (Figure 4) .
IMZ Had Binding Characteristics With CFTR and SLC26 Family Protein
Molecular docking experiments were used to provide insight into the interactions between IMZ and mouse CFTR and SLC26 family proteins. As shown in Figure 5 , IMZ docks into the binding pocket of CFTR ( Figure 5A ) and SLC26 family ( Figure 5B ). Detailed analysis revealed that key hydrogen bonds are formed by nitrogen atoms of the imidazole bond with Val440 and Ala697. The binding affinities of IMZ with CFTR and the SLC26 family were scored using the Vina docking score algorithm. The binding scores obtained for IMZ with CFTR and the SLC26 family were À4.9 and À6.0 kcal/mol, respectively.
The Gut Microbiota Composition and Ionic Transport Function Could be Recovered After IMZ Exposure
To determine whether IMZ-induced gut microbiota dysbiosis can reverse by itself, the mice treated with 2.5 mg/kg IMZ for 15 weeks were then allowed to recover for 45 days. The relative abundances of Bacteroidetes, Firmicutes, a-Proteobacteria, b-Proteobacteria, and c-Proteobacteria at phylum level in cecal contents returned to the same levels as the control group ( Figure 6A) . In fact, all of fecal microbiota that differed at phylum level could be recovered to the control level after 30 or 45 days (Figs. 6B-G) . Furthermore, the protein levels of CFTR, NKCC1, and SLC26A3 in ileum reverted to control values, whereas the colon failed to recuperate in the IMZexposed mice after 45 days of recovery (Figs. 6H-M) . The presented values are the means 6 SE (n ¼ 5). An asterisk indicates a significant difference (*p < .05) between the control-and IMZ-treated groups.
DISCUSSION
Several previous studies reported that IMZ exposure could result in a variety of toxic effects on different test models, such as dermatitis and eczema in rats, endocrine dysfunction in mice, and nervous system dysfunction in zebrafish (Tanaka, 1995; Tanaka et al., 2013; Nakagawa and Tayama, 1997; Jin et al., 2016b Jin et al., , 2017a . Recently, a study by our group reported that acute IMZ exposure induced gut microbiota dysbiosis and colonic inflammation in male ICR mice (Jin et al., 2016a) . To our knowledge, little is known about the effects of chronic IMZ exposure on gut microbiota and its subsequent influences. In order to research how quickly IMZ affects the gut microbiota and how severe will the subsequent damage be after gut microbiota dysbiosis at different times of IMZ-exposure. Furthermore, it is also interesting to analyze whether the gut function would be affect by subchronic and chronic IMZ exposure. During the exposure, we analyzed the change of composition of gut microbiota in the feces every week, and observed that the gut microbiota changed at 2 weeks, eased at 5 weeks, and stabilized at 15 weeks in the feces. Thus, the exposure period of 2, 5, and 15 weeks was selected in this study. Here, we were the first to demonstrate that the long-term administration of IMZ at doses of 0.1, 0.5, and 2.5 mg/kg/day indeed led to gut microbiota dysbiosis, metabolic disorder, and intestinal barrier dysfunction in C57BL/6 mice. Dynamic microbe-microbe and microbe-host interactions may lead to different developmental consequences for the host. In the gastrointestinal tract, the microcommunity, also known as the gut microbiota, that developed along with our immune system provides multiplex metabolic and anti-invasion possibilities (Thomas et al., 2017; Zmora et al., 2017) . In normal conditions, gut microbiota is relatively stable and has beneficial effects on the body (Brü ssow, 2016) . Indeed, the composition of gut microbiota can be influenced by many factors, such as food (He et al., 2013) , medicine (Brü ssow, 2015) , and even environmental chemicals (Jin et al., 2017b; Rother et al., 2015) . IMZ, as a widely used type of fungicide, may have the potential to influence the composition of the gut microbiota. According to our previous study, after short-term exposure to a high dose of IMZ, the relative abundance of Bacteroidetes, Firmicutes, and Actinobacteria in the cecal contents decreased significantly, whereas in the feces, the relative abundance in Bacteroidetes, Firmicutes, and Actinobacteria decreased significantly after being exposed IMZ for 1, 7, and 14 days, respectively (Jin et al., 2016a,b) . Not surprisingly, all the qPCR and high-throughput sequencing results in the present study indicated that oral administration of IMZ to adult mice disturbed the balance of the gut microbiota, and the Bacteroidetes, one of the main phyla of gut microbes in mice, was significantly underrepresented in the cecal contents over 2 weeks during the long-term study (Figure 1) . Interestingly, although the relative abundance changes of mice microbiota in the feces were persistent (Figs. 1D-I) , the changes in the cecal contents were abnormal and unpredictable. The relative abundance of Firmicutes in mice cecum, for example, was rebounded after 5 weeks of IMZ administration. Such abnormalities indicated that, in the different part of the intestine, the living environment, especially the microbes supplement (microbes come from the proximal part of gastrointestinal tract) and the nutritional condition may also play a very important role in the responds of mice gut microbiota to the IMZ intervention. Likewise, sequencing analysis revealed that IMZ-exposure varied the OTUs and richness of gut microbiota (Figure 2 and Table 1 ). This implies the possibility of effects on multiple intestinal functions, such as the capacity for digestion and absorption, metabolism, biophylaxis, and others (Zmora et al., 2017) . On the other hand, it also accentuates the risk of bacteria invading the intestinal mucosa and causing infection (Everard et al., 2013; Natividad and Verdu, 2013) . Through our analysis, we found that the ratio of bacterial 16S to 18S in the colon was elevated significantly ( Figure 3H ). That is, chronic exposure to IMZ greatly increased the amount of bacterial infection in the colonic mucosa of mice and may thereby influence intestinal barrier function. Furthermore, based on the sequencing data and the pertinent literature, we have identified some gut microbiota that changed at the species level and the possible physiological roles of those bacteria (Supplementary Table 1 ). The abundances of Prevotella, Oscillospira, Helicobacteraceae, Bacteroides acidifaciens, Parabacteroides distasonis, and Lactobacillus reuteri were all significantly different from the values in the control group and were frequently associated with aspects of intestinal barrier function, such as mucus secretion, inflammatory reaction, and immune function (Ahl et al., 2016; Hofer, 2014; Kaakoush et al., 2010; Kan et al., 2016; Kverka et al., 2011; Konikoff and Gophna, 2016; Yanagibashi et al., 2013) . Generally, studies on 16S rRNA analysis were often conducted without the bias in the processes of DNA extraction, PCR amplification, sequencing, taxonomic classification, and other conditions, but in fact, which could result in dramatically different results (Brooks et al., 2015) . In this study, our main objective is to analyze the changes of the whole gut microbiota and the possible effects after analyzing by PCR and 16S rRNA gene sequencing, and more precise analysis the species level of gut microbiota requires advances in sequencing.
Usually, undigested dietary fibers as well as proteins and peptides that escape digestion by host enzymes in the upper gut can be fermented in the cecum and colon by gut microbiota. And the gut microbiota metabolic products are of utmost importance to the host gut; their functions include providing nutrients to IECs and energy to the host, maintaining the homeostatic control of electrolytes and fluid balance, and regulating the function of intestine. The functions of the intestine as a secretory and absorptive organ impact the mucosal defenses and the characteristics of the intestinal microbiota (Farkas et al., 2011; Keely et al., 2012) . Through colonic AB-PAS staining, we found a decline in intestinal mucus secretion, whereas the colonic genes associated with mucus secretion were significantly up-regulated at 15 weeks (Figure 3) . Furthermore, Meprin-b, a metalloendopeptidase, involved in the detachment and release of mucus from goblet cells (Schü tte et al., 2014) . The resistin, Retnlb, in addition to acting as a broad-spectrum antibacterial, also promotes the repair and regeneration of IECs when the intestinal barrier is damaged, and its increased expression may relate to destruction of the mucus layer, increases in intestinal permeability and bacterial translocation (Bhatia et al., 2015) . The increased expression of mucus secretion-related genes may Figure 6 . Microbiota composition and levels of ionic transport protein during recovery. Mice were fed 2.5 mg IMZ/kg body weight for 15 weeks and then allowed to recover for 45 days whereas feces were collected. A, Relative abundance of Bacteroidetes, Firmicutes, Actinobacteria, a-Proteobacteria, b-Proteobacteria, and c-Proteobacteria in cecal contents after 45 days' recovery. BÀG, Changes in the relative abundance of fecal Bacteroidetes, Firmicutes, Actinobacteria a-Proteobacteria, b-Proteobacteria, and c-Proteobacteria during the 45-day recovery period. HÀM, The ELISA results of CFTR, NKCC1, and SLC26A3 in the ileum and colon after 45 days' recovery. The presented values are the means 6 SEM (n ¼ 6). *p < .05 versus control. prompt a compensatory phenomenon for mucus layer damage ( Figure 3G ).
The CFTR, as a cAMP-activated epithelial Cl À and HCO 3À channel (Poulsen et al., 1994) , plays a critical role in the regulation of epithelial secretion in the intestinal canal (Murek et al., 2010) , and its dysfunction allows abnormal bacterial colonization (Lynch et al., 2013; Norkina et al., 2004) . The intestinal capacity to secrete Cl À is also dependent on NKCC1, which mediates Cl À uptake from the basolateral pole of IECs, thereby providing Cl -for apical secretion via CFTR (Murek et al., 2010) .
Interestingly, gene expression of the major ionic transporters in the ileum and colon was decreased significantly in a dose-and time-dependent manner (Figs. 4A-C and G-I). In both the ileum and the colon, the protein levels of CFTR, NKCC1, and SLC26A3 were all significantly down-regulated (Figs. 4D-F and J-L). We thus concluded that low doses of IMZ rapidly affected ion transport in the intestine via its down-regulation of NKCC1 and CFTR function. In addition, we used molecular docking experiments to provide insight into the interactions between the IMZ and mouse CFTR and SLC26 family proteins (Trott and Olson, 2010) . Detailed analysis revealed that key hydrogen bonds are formed by nitrogen atoms of the imidazole bond ( Figure 5 ), indicating that IMZ can act on the ion channel protein directly. And the possibility that IMZ may affect intestinal barrier function directly could not be ruled out. A large amount of evidence indicated that there was a strong relationship among the gut microbiota and intestinal barrier function (Bhatia et al., 2015; Natividad and Verdu, 2013; Zmora et al., 2017) . Although the qPCR and sequencing have methodological weaknesses, current reporting and the changes of mucus secretion and intestinal ion translocation all illustrated that there is a correlation between varying gut microbiota and tissue response. The study observed that IMZ altered the composition of the gut microbiota, mucus secretion, and ion translocation after 15-week chronic exposure. The potential mechanism underlying the influence of chronic IMZ exposure on microbiota dysbiosis and intestinal barrier dysfunction is briefly depicted in Figure 7 . Briefly, low doses of IMZ altered the diversity and richness of the gut microbiota in cecal contents, feces, and colonic mucosa. Meanwhile, mucus secretion declined and ion transport capacity weakened after chronic IMZ exposure. Because of its widespread use, IMZ can potentially enter the human body by many different routes. The data presented in this study provide new and specific evidence that exposure to IMZ Chronic IMZ exposure directly induced gut microbiota dysbiosis, decreased the amount of mucus secretion and reduced the expression of some major ionic transporters, which thus affecting intestinal barrier function in mice.
causes a change in the gut microbiota composition and induces intestinal barrier dysfunction in mice. More importantly, although the composition of the gut microbiota could be partially recovered after 45 days, ileal ion channel proteins reverted and the colon still could not be restored (Figure 6 ). Therefore, the potential threat that IMZ poses to human health should not be ignored.
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